These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24757205)

  • 1. Update of retraction--Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy. Diabetes. 19 November 2012 [Epub ahead of print]. DOI: 10.2337/db12-0317.
    Diabetes; 2014 May; 63(5):1817. PubMed ID: 24757205
    [No Abstract]   [Full Text] [Related]  

  • 2. Statement of Retraction. Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy. Diabetes. 19 November 2012 [Epub ahead of print].
    Rincon N; Xu K; Li J; Martinez JA; Singh GS; Han D; Lalli P; Ayer A; Tse K; Rong L; Schmidt AM; Toth CC
    Diabetes; 2013 Jan; 62(1):309. PubMed ID: 22936180
    [No Abstract]   [Full Text] [Related]  

  • 3. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy.
    Chiarelli F; Mansour M; Verrotti A
    Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy.
    Hammes HP; Alt A; Niwa T; Clausen JT; Bretzel RG; Brownlee M; Schleicher ED
    Diabetologia; 1999 Jun; 42(6):728-36. PubMed ID: 10382593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.
    Park L; Raman KG; Lee KJ; Lu Y; Ferran LJ; Chow WS; Stern D; Schmidt AM
    Nat Med; 1998 Sep; 4(9):1025-31. PubMed ID: 9734395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population.
    Picheth G; Heidemann M; Pedrosa FO; Chautard-Freire-Maia EA; Costantini CO; da Rocha Martinez TL; de Souza EM
    Clin Chim Acta; 2007 Aug; 383(1-2):163-4. PubMed ID: 17512509
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.
    Bierhaus A; Haslbeck KM; Humpert PM; Liliensiek B; Dehmer T; Morcos M; Sayed AA; Andrassy M; Schiekofer S; Schneider JG; Schulz JB; Heuss D; Neundörfer B; Dierl S; Huber J; Tritschler H; Schmidt AM; Schwaninger M; Haering HU; Schleicher E; Kasper M; Stern DM; Arnold B; Nawroth PP
    J Clin Invest; 2004 Dec; 114(12):1741-51. PubMed ID: 15599399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes, leukoencephalopathy and rage.
    Toth C; Schmidt AM; Tuor UI; Francis G; Foniok T; Brussee V; Kaur J; Yan SF; Martinez JA; Barber PA; Buchan A; Zochodne DW
    Neurobiol Dis; 2006 Aug; 23(2):445-61. PubMed ID: 16815028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus.
    Mallidis C; Agbaje I; Rogers D; Glenn J; McCullough S; Atkinson AB; Steger K; Stitt A; McClure N
    Hum Reprod; 2007 Aug; 22(8):2169-77. PubMed ID: 17588956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis.
    Hoffman WH; Artlett CM; Zhang W; Kreipke CW; Passmore GG; Rafols JA; Sima AA
    Brain Res; 2008 Oct; 1238():154-62. PubMed ID: 18775683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.